Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

2007 ◽  
Vol 37 (2) ◽  
pp. 445-455 ◽  
Author(s):  
Andrea De Maria ◽  
Manuela Fogli ◽  
Stefania Mazza ◽  
Monica Basso ◽  
Antonio Picciotto ◽  
...  
2020 ◽  
Vol 142 ◽  
pp. 103230
Author(s):  
Ayano Yamaya ◽  
Atsushi Fukui ◽  
Rie Fukuhara ◽  
Yoshihito Yokoyama ◽  
Hiroaki Shibahara

PLoS ONE ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. e0193008 ◽  
Author(s):  
Kelly E. Bowen ◽  
Stephen O. Mathew ◽  
Kathleen Borgmann ◽  
Anuja Ghorpade ◽  
Porunelloor A. Mathew

2019 ◽  
Vol 15 (4) ◽  
pp. e1007725 ◽  
Author(s):  
Katharina Pallmer ◽  
Isabel Barnstorf ◽  
Nicolas S. Baumann ◽  
Mariana Borsa ◽  
Stipan Jonjic ◽  
...  

Placenta ◽  
2015 ◽  
Vol 36 (10) ◽  
pp. A13-A14
Author(s):  
Hideki Takahashi ◽  
Yusuke Kobayashi ◽  
Souichirou Kuno ◽  
Takayuki Matsuno ◽  
Takayuki Matsuno ◽  
...  

2015 ◽  
Vol 112 ◽  
pp. 130-131
Author(s):  
Hideki Takahashi ◽  
Yusuke Kobayashi ◽  
Souichirou Kuno ◽  
Takayuki Matsuno ◽  
Takayuki Murase ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 156
Author(s):  
Jasmina M. Luczo ◽  
Sydney L. Ronzulli ◽  
Stephen M. Tompkins

Natural killer (NK) cells are part of the innate immunity repertoire, and function in the recognition and destruction of tumorigenic and pathogen-infected cells. Engagement of NK cell activating receptors can lead to functional activation of NK cells, resulting in lysis of target cells. NK cell activating receptors specific for non-major histocompatibility complex ligands are NKp46, NKp44, NKp30, NKG2D, and CD16 (also known as FcγRIII). The natural cytotoxicity receptors (NCRs), NKp46, NKp44, and NKp30, have been implicated in functional activation of NK cells following influenza virus infection via binding with influenza virus hemagglutinin (HA). In this review we describe NK cell and influenza A virus biology, and the interactions of influenza A virus HA and other pathogen lectins with NK cell natural cytotoxicity receptors (NCRs). We review concepts which intersect viral immunology, traditional virology and glycobiology to provide insights into the interactions between influenza virus HA and the NCRs. Furthermore, we provide expert opinion on future directions that would provide insights into currently unanswered questions.


2012 ◽  
Vol 35 (4) ◽  
pp. 594-600 ◽  
Author(s):  
Kenichiro Ito ◽  
Koji Higai ◽  
Chihiro Shinoda ◽  
Mizuha Sakurai ◽  
Kazuyuki Yanai ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (38) ◽  
pp. 64344-64357 ◽  
Author(s):  
Kimberly Mayes ◽  
Zeinab Elsayed ◽  
Aiman Alhazmi ◽  
Michael Waters ◽  
Suehyb G. Alkhatib ◽  
...  

2020 ◽  
Vol 9 (1) ◽  
pp. 143 ◽  
Author(s):  
Cinzia Fionda ◽  
Helena Stabile ◽  
Cristina Cerboni ◽  
Alessandra Soriani ◽  
Angela Gismondi ◽  
...  

Transforming growth factor (TGF)-β is a central immunosuppressive cytokine within tumor microenvironment inhibiting the expansion and function of major cellular components of adaptive and innate immune system. Among them, compelling evidence has demonstrated that TGF-β is a key regulator of natural killer (NK) cells, innate lymphoid cells (ILCs) with a critical role in immunosurveillance against different kinds of cancer cells. A TGF-β rich tumor microenvironment blocks NK cell activity at multiple levels. This immunosuppressive factor exerts direct regulatory effects on NK cells including inhibition of cytokine production, alteration of activating/inhibitory receptor expression, and promotion of the conversion into non cytotoxic group I ILC (ILC1). Concomitantly, TGF-β can render tumor cells less susceptible to NK cell-mediated recognition and lysis. Indeed, accumulating evidence suggest that changes in levels of NKG2D ligands, mainly MICA, as well as an increase of immune checkpoint inhibitors (e.g., PD-L1) and other inhibitory ligands on cancer cells significantly contribute to TGF-β-mediated suppression of NK cell activity. Here, we will take into consideration two major mechanisms underlying the negative regulation of ILC function by TGF-β in cancer. First, we will address how TGF-β impacts the balance of signals governing NK cell activity. Second, we will review recent advances on the role of this cytokine in driving ILC plasticity in cancer. Finally, we will discuss how the development of therapeutic approaches blocking TGF-β may reverse the suppression of host immune surveillance and improve anti-tumor NK cell response in the clinic.


Sign in / Sign up

Export Citation Format

Share Document